Notice of Change to PHS Assignment Request Form in RFA-DK-17-011 "Catalyst Award in Diabetes, Endocrinology and Metabolic Diseases (DP1- Clinical Trials Not Allowed)"

Notice Number: NOT-DK-17-020

Key Dates
Release Date:  September 21, 2017

Related Announcements
RFA-DK-17-011

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to change instructions provided in Section IV.2, PHS Assignment Request Form of RFA-DK-17-011 "Catalyst Award in Diabetes, Endocrinology and Metabolic Diseases (DP1-Clinical Trials Not Allowed" to eliminate specific instructions regarding incorporation of references, figures and illustrations, and letters of collaboration.

Currently:
Section IV.2, PHS Assignment Request Form
All instructions in the SF424 (R&R) Application Guide must be followed. Since all applications received in response to this FOA are assigned to a single Special Emphasis Panel and to the NIDDK, do not suggest assignment to a specific study section. Since letters of collaboration and biosketches of collaborators are not allowed, provide the names of collaborators as Individuals who should not review your application to identify them for exclusion during reviewer assignment. References are not required but if included must fit within the page limit.  Figures and illustrations may be included but must also fit within the page limit.  Letters of collaboration will not be accepted.  Information on collaborators may be included in the Essay and their names and affiliations should be listed in the
Cover Letter.

Cover Letter: List significant collaborators for the proposed Catalyst Award project. Letters of collaboration and biosketches of collaborators are not allowed. Provision of names here is only to help exclude conflicts during reviewer assignment. Information regarding any collaborators may be included in the Essay.

Modified to read:
Section IV.2, PHS Assignment Request Form
All instructions in the SF424 (R&R) Application Guide must be followed. Since all applications received in response to this FOA are assigned to a single Special Emphasis Panel and to the NIDDK, do not suggest assignment to a specific study section. Since letters of collaboration and biosketches of collaborators are not allowed, provide the names of collaborators as Individuals who should not review your application to identify them for exclusion during reviewer assignment.

All other aspects of this Funding Opportunity Announcement remain the same.

Inquiries

Please direct all inquiries to:

Kristin M. Abraham, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-451-8048
Email: abrahamk@mail.nih.gov